Mustang Bio Inc (NASDAQ:MBIO)’s traded shares stood at 40.84 million during the last session, with the company’s beta value hitting 1.96. At the close of trading, the stock’s price was $0.30, to imply an increase of 7.37% or $0.02 in intraday trading. The MBIO share’s 52-week high remains $2.11, putting it -603.33% down since that peak but still an impressive 56.67% since price per share fell to its 52-week low of $0.13. The company has a valuation of $11.28M, with an average of 6.8 million shares in intraday trading volume over the past 10 days and average of 1.45 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Mustang Bio Inc (MBIO), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give MBIO a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mustang Bio Inc (NASDAQ:MBIO) trade information
After registering a 7.37% upside in the last session, Mustang Bio Inc (MBIO) has traded red over the past five days. The 5-day price performance for the stock is 37.81%, and 40.43% over 30 days. With these gigs, the year-to-date price performance is -77.56%. Short interest in Mustang Bio Inc (NASDAQ:MBIO) saw shorts transact 0.38 million shares and set a 0.64 days time to cover.
Mustang Bio Inc (MBIO) estimates and forecasts
Looking at statistics comparing Mustang Bio Inc share performance against respective industry, we note that the company has outperformed competitors. Mustang Bio Inc (MBIO) shares are -13.48% down over the last 6 months, with its year-to-date growth rate higher than industry average at 86.50% against 17.40%.
MBIO Dividends
Mustang Bio Inc has its next earnings report out on 2024-Mar-11. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Mustang Bio Inc (NASDAQ:MBIO)’s Major holders
Mustang Bio Inc insiders hold 7.56% of total outstanding shares, with institutional holders owning 2.31% of the shares at 2.50% float percentage. In total, 2.31% institutions holds shares in the company.
We also have Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Mustang Bio Inc (MBIO) shares. Going by data provided on Jun 30, 2024 , Vanguard Extended Market Index Fund holds roughly 73.42 shares. This is just over 0.20% of the total shares, with a market valuation of $22238.0. Data from the same date shows that the other fund manager holds a little less at 56.62, or 0.16% of the shares, all valued at about 17149.0.
